Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORCE2: CHF 1535 vs CHF 718 in Adults With Asthma
NCT05292586Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2022
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Aug 2022; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05292586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05292586.